Resumo
Introduction: Osteoporosis is a chronic disease characterized by a decrease in the density of bone mass, making bone more porous, less resistant and of lower quality than normal bone. This leads to the deterioration of its microstructure, making the bone more fragile and therefore increasing the risk of fracture. It has been found that high concentrations of Lactobacillus and Bifidobacteria promote the absorption of minerals such as calcium, magnesium, and phosphorus and thus increase mineral density. Due to the great social and economic impacts of osteoporosis, it is necessary to develop interventions that can be easily adopted at the population level, improving the quality of life of individuals without significantly affecting the health system.
Objective. Evaluate the impact of increased consumption of dairy foods in the Colombian population with osteoporosis from 2015 to 2020 by simulating the potential impact fraction (PIF).
Methods. Using data from the Integrated Social Protection Information System (SISPRO) and National Nutritional Situation Survey (ENSIN), the incidence, the frequency of milk consumption, the potential impact fraction (PIF), and disability-adjusted life years (DALYs) were estimated.
Results. A total of 63 640 cases of osteoporosis were identified. The highest incidence was observed in 2019. Seventeen food groups were identified in the ENSIN, and the most frequent products consumed by respondents over 50 years of age were milk, cheese, and yogurt. The PIF was then analysed, with a calcium intake of 600 mg/day, and a significant difference in the decrease in the number of cases was observed. In 2019, a higher estimated DALY loss of 9.9 was observed. In women, years of life lost due to fractures was highest in the 65-69 age group. In men, it was highest in the 75-79 years age group.
Conclusion. Years lost due to disability increased in the population over 60 years of age. In the PIF analysis, a decrease in cases was observed when the population increased consumption of dairy products.
Referências
NIH Consensus development panel on osteoporosis prevention, diagnosis, and therapy. (2001). Osteoporosis prevention, diagnosis, and therapy. JAMA. 2001; 285(6): 785–795. https://doi. org/10.1001/jama.285.6.785
Cosman F, de Beur SJ, LeBoff MS, Lewiecki, EM, Tanner B, Randall S, et al. Clinician’s guide to prevention and treatment of osteoporosis. Osteoporos Int. 2015; 25(10): 2359–2381. doi: https://doi.org/10.1007/s00198-014-2794-2
Curtis EM, van der Velde R, Moon RJ, van den Bergh JP, Geusens P, de Vries F, et al. Epidemiology of fractures in the United Kingdom 1988–2012: Variation with age, sex, geography, ethnicity and socioeconomic status. Bone. 2016; 87: 19–26. https://doi.org/10.1016/j.bone.2016.03.006
Bruscoli S, Febo M, Riccardi C, Migliorati G. Glucocorticoid therapy in inflammatory bowel disease: Mechanisms and clinical practice. Front Immunol. 2021; 12: 691480. doi: 10.3389/ fimmu.2021.691480
Li Q, Lauber CL, Czarnecki-Maulden G, Pan Y, Hannah SS. Effects of the dietary protein and carbohydrate ratio on gut microbiomes in dogs of different body conditions. mBio. 2017; 8(1): e01703-16. doi: 10.1128/mBio.01703-16
Eaimworawuthikul S, Thiennimitr P, Chattipakorn N, Chattipakorn SC. Diet-induced obesity, gut microbiota and bone, including alveolar bone loss. Arch Oral Biol. 2017; 78: 65-81. doi: 10.1016/j. archoralbio.2017.02.009
Ding K, Hua F, Ding W. Gut microbiome and osteoporosis. Aging Dis. 2020; 11(2): 438-447. doi: 10.14336/AD.2019.0523
Clarke G, Stilling RM, Kennedy PJ, Stanton C, Cryan JF, Dinan TG. Minireview: Gut microbiota: the neglected endocrine organ. Mol Endocrinol. 2014; 28(8): 1221-1238. doi: 10.1210/me.2014- 1108
Desfita S, Sari W, Yusmarini Y, Pato U, Zakłos- Szyda M, Budryn G. Effect of fermented soymilk-honey from different probiotics on osteocalcin level in menopausal women. Nutrients. 2021; 13(10): 3581. doi: 10.3390/nu13103581
Miller GD, Kanter M, Rycken L, Comerford KB, Gardner NM, Brown KA. Food systems transformation for child health and well-being: The essential role of dairy. Int J Environ Res Public Health. 2021; 18(19): 10535. doi: 10.3390/ ijerph181910535
Rizzoli R, Biver E. Are probiotics the new calcium and vitamin D for bone health? Curr Osteoporos Rep. 2020; 18(3): 273-284. doi: 10.1007/s11914- 020-00591-6
Lucas S, Omata Y, Hofmann J, Böttcher M, Iljazovic A, Sarter K, et al. Short-chain fatty acids regulate systemic bone mass and protect from pathological bone loss. Nat Commun. 2018; 9(1): 55. doi: 10.1038/s41467-017-02490-4
Fernández-Ávila DG, Bernal-Macías S, Parra MJ, Rincón DN, Gutiérrez JM, Rosselli D. Prevalence of osteoporosis in Colombia: Data from the National Health Registry from 2012 to 2018. Reumatol Clin (Engl Ed). 2021; 17(10):570-574. doi: 10.1016/j. reumae.2020.07.009
Aziziyeh R, Amin M, Habib M, Garcia Perlaza J, Szafranski K, McTavish RK, et al. The burden of osteoporosis in four Latin American countries: Brazil, Mexico, Colombia, and Argentina. J Med Econ. 2019; 22(7): 638-644. doi: 10.1080/13696998.2019.1590843
Morales-Torres J, Gutiérrez-Ureña S; Osteoporosis Committee of Pan-American League of Associations for Rheumatology. The burden of osteoporosis in Latin America. Osteoporos Int. 2004 Aug;15(8):625- 32. doi: 10.1007/s00198-004-1596-3
Johnell O, Kanis JA. An estimate of the worldwide prevalence and disability associated with osteoporotic fractures. Osteoporos Int. 2006; 17(12): 1726-1733. doi: 10.1007/s00198-006-0172-4
Departamento Administrativo Nacional de Estadística (DANE) [Internet]. Bogotá: DANE; c2022. Proyecciones de población. (n.d.) [Cited January 10, 2023]. Available at: https://www. dane.gov.co/index.php/estadisticas-por-tema/ demografia-y-poblacion/proyecciones-de-poblacion
Instituto Colombiano de Bienestar Familiar (ICBF). ENSIN: Encuesta Nacional de Situación Nutricional [Internet]. Bogotá: ICBF; 2015. Available at: https:// www.icbf.gov.co/bienestar/nutricion/encuesta-nacional-situacion-nutricional
Coy A, Medina A, Rivera A, Sánchez P. Calcium intake in Colombia: are we still in deficit? Arch Osteoporos. 2020; 15(1): 71. doi: 10.1007/s11657- 020-00740-5
Cumming RG, Nevitt MC. Calcium for prevention of osteoporotic fractures in postmenopausal women. J Bone Miner Res. 1997; 12(9): 1321-1329. doi: 10.1359/jbmr.1997.12.9.1321
Balk EM, Adam GP, Langberg VN, Earley A, Clark P, Ebeling PR, et al. Global dietary calcium intake among adults: A systematic review. Osteoporos Int. 2017; 28(12): 3315-3324. doi: 10.1007/s00198- 017-4230-x
World Health Organization. Department of Data and Analytics. WHO methods and data sources for global burden of disease estimates 2000-2019 [Internet]. Geneva: WHO; 2020. Available at: https://cdn.who.int/media/docs/default-source/gho-documents/global-health-estimates/ghe2019_daly-methods.pdf?sfvrsn=31b25009_7
Reginster JY, Burlet N. Osteoporosis: a still increasing prevalence. Bone. 2006; 38(2 Suppl 1): S4-9. doi: 10.1016/j.bone.2005.11.024
Tricarico JM, Kebreab E, Wattiaux MA. MILK Symposium review: Sustainability of dairy production and consumption in low-income countries with emphasis on productivity and environmental impact. J Dairy Sci. 2020; 103(11): 9791-9802. doi: 10.3168/jds.2020-18269
Hernlund E, Svedbom A, Ivergård M, Compston J, Cooper C, Stenmark J, et al. Osteoporosis in the European Union: medical management, epidemiology and economic burden. A report prepared in collaboration with the International Osteoporosis Foundation (IOF) and the European Federation of Pharmaceutical Industry Associations (EFPIA). Arch Osteoporos. 2013; 8(1): 136. doi: 10.1007/s11657-013-0136-1
Malagón-Rojas J, Mendez-Molano D, Almentero J, Toloza-Pérez YG, Parra-Barrera EL, Gómez- Rendón CP. Environmental effects of the COVID-19 pandemic: The experience of Bogotá, 2020. Int J Environ Res Public Health. 2022; 19(10): 6350. doi: 10.3390/ijerph19106350
Kanis JA, Cooper C, Rizzoli R, Reginster JY, Scientific Advisory Board of the European Society for clinical and economic aspects of osteoporosis (ESCEO) and the Committees of Scientific Advisors and National Societies of the International Osteoporosis Foundation (IOF). European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int. 2019; 30(1): 3-44. doi: 10.1007/s00198-018-4704-5
Compston J, Cooper A, Cooper C, Gittoes N, Gregson C, Harvey N, et al. UK clinical guideline for the prevention and treatment of osteoporosis. Arch Osteoporos. 2017; 12(1): 43. doi: 10.1007/ s11657-017-0324-5
Este trabalho está licenciado sob uma licença Creative Commons Attribution 4.0 International License.
Copyright (c) 2023 Norida Nataly Vélez-Cuellar, Yesith Guillermo Toloza-Pérez, Jeadran Malagón-Rojas